Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDNovo Nordisk A/S Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | $6.45 | $6.64 | $6.55 |
| Q2 2025 | 1 | $6.43 | $6.62 | $6.52 |
| Q3 2025 | 1 | $7.39 | $7.61 | $7.50 |
| Q4 2025 | 1 | $7.09 | $7.29 | $7.19 |
Novo Nordisk A/S Earnings Date And Information
Novo Nordisk A/S last posted its earnings results on Wednesday, November 6th, 2024. The company reported $0.9 earnings per share for the quarter, missing analysts' consensus estimates of $0.91 by $0.01. The company had revenue of 71.31 B for the quarter and had revenue of 232.26 B for the year. Novo Nordisk A/S has generated $9 earnings per share over the last year ($9.31 diluted earnings per share) and currently has a price-to-earnings ratio of 27.74. Novo Nordisk A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based on prior year's report dates.
Novo Nordisk A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/28/2024 | Q3 2024 | $6.13 | $70.57 B | $71.31 B | ||
| 06/29/2024 | Q2 2024 | $4.50 | $69.28 B | $68.06 B | ||
| 03/30/2024 | Q1 2024 | $5.70 | $65.35 B | |||
| 12/30/2023 | Q4 2023 | $4.92 | $65.86 B | |||
| 09/29/2023 | Q3 2023 | $5.02 | $57.80 B | $58.73 B | ||
| 06/29/2023 | Q2 2023 | $8.65 | $56.03 B | $54.30 B | ||
| 03/30/2023 | Q1 2023 | $8.81 | $53.37 B | |||
| 12/30/2022 | Q4 2022 | $6.01 | $48.09 B | |||
| 09/29/2022 | Q3 2022 | $3.17 | $44.89 B | $45.57 B | ||
| 06/29/2022 | Q2 2022 | $2.93 | $40.76 B | $41.27 B | ||
| 03/30/2022 | Q1 2022 | $3.11 | $42.03 B | |||
| 12/30/2021 | Q4 2021 | $4.75 | $38.33 B | |||
| 09/29/2021 | Q3 2021 | $5.29 | $34.56 B | $35.62 B | ||
| 06/29/2021 | Q2 2021 | $5.26 | $32.35 B | $33.04 B | ||
| 03/30/2021 | Q1 2021 | $5.47 | $33.80 B | |||
| 12/30/2020 | Q4 2020 | $4.00 | $32.14 B | |||
| 09/29/2020 | Q3 2020 | $4.42 | $30.93 B | $30.93 B | ||
| 06/29/2020 | Q2 2020 | $4.54 | $31.52 B | $30.01 B | ||
| 03/30/2020 | Q1 2020 | $5.07 | $33.88 B | |||
| 12/30/2019 | Q4 2019 | $3.68 | $32.42 B |
Novo Nordisk A/S Earnings: FAQ's
When is Novo Nordisk A/S's earnings date?
Novo Nordisk A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based off last year's report dates.
How can I listen to Novo Nordisk A/S's earnings conference
call?
The conference call for Novo Nordisk A/S's latest earnings report can be listened to online.
How can I read Novo Nordisk A/S's conference call transcript?
The conference call transcript for Novo Nordisk A/S's latest earnings report can be read online.
How much revenue does Novo Nordisk A/S generate each year?
Novo Nordisk A/S (:NVO) has a recorded annual revenue of $232.26 B.
How much profit does Novo Nordisk A/S generate each year?
Novo Nordisk A/S (:NVO) has a recorded net income of $232.26 B. Novo Nordisk A/S has generated $9.335 earnings per share over the last four quarters.
What is Novo Nordisk A/S's price-to-earnings ratio?
Novo Nordisk A/S (:NVO) has a price-to-earnings ratio of 27.74 and price/earnings-to-growth ratio is 5.03.